Brief: Theratechnologies Submits SBLA For Trogarzo® INTRAMUSCULAR (IM) METHOD To FDA

Theratechnologies

02/01/2024 12:43

Jan 2 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES SUBMITS SBLA FOR TROGARZO® INTRAMUSCULAR
(IM)
METHOD OF ADMINISTRATION TO FDA
    * EXPECTS TO RECEIVE ACKNOWLEDGMENT LETTER OF SBLA
APPLICATION
WITHIN 30 DAYS ALONG WITH PRESCRIPTION DRUG USER FEE ACT GOAL
DATE

Source text for Eikon:  ID:nGNX3XsPKg 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))